5-ht5A receptors as a therapeutic target

Pharmacology and Therapeutics

Volumn 111, Issue 3, 2006, Pages 707-714

  Thomas, David R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 ht5A receptor; Gene association; Pharmacology; Receptor function; Tissue localization

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 5 CARBAMOYLTRYPTAMINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLOZAPINE; ERGOTAMINE; ISOTOPE; LYSERGIDE; MESSENGER RNA; MESULERGINE; METERGOLINE; METITEPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; RECEPTOR PROTEIN; RITANSERIN; SB 269970 A; SB 656104 A; SB 699551 A; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 5A RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SUMATRIPTAN; SEROTONIN 5 RECEPTOR; SEROTONIN RECEPTOR;

ANTIBODY LABELING; BEHAVIOR; BEHAVIORAL SCIENCE; BRAIN CORTEX; CIRCADIAN RHYTHM; COGNITIVE DEFECT; DATA ANALYSIS; DISEASE ASSOCIATION; GENE LOCATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; KNOCKOUT MOUSE; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SLEEP DISORDER; SUPRACHIASMATIC NUCLEUS; ANIMAL; CLASSIFICATION; DRUG EFFECT; GENETICS; PHYSIOLOGY;

ANIMALS; CIRCADIAN RHYTHM; HUMANS; MOOD DISORDERS; RECEPTORS, SEROTONIN; RNA, MESSENGER; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS;

EID: 33746733586     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.12.006     Document Type: Review

References (62)

1. 5A receptor gene in patients with bipolar disorder and major depression. Neurosci Lett 303 (2001) 111-114
2. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
3. 5A gene in depression, psychosis and antipsychotic response. NeuroReport 11 (2000) 2017-2020
4. Blier P., and De Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21 (1999) S91-S98
5. Bobee S., Mariette E., Tremblay-Leveau H., and Caston J. Effects of early midline cerebellar lesion on cognitive and emotional functions in the rat. Behav Brain Res 112 (2000) 107-117
6. 5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes. Glia 17 (1996) 317-326
7. Chen J.J., Vasko M.R., Wu X., Staeva T.P., Baez M., Zgombick J.M., et al. Multiple subtypes of serotonin receptors are expressed in rat sensory neurones in culture. J Pharmacol Exp Ther 287 (1998) 1119-1127
8. 1A receptors in the control of the micturition reflex in male anaesthetized rats. Br J Pharmacol 133 (2001) 61-72
9. 5A receptor antagonist by high throughput chemistry. Bioorg Med Chem Lett 15 (2005) 4014-4018
10. Dijk D.J., and Czeisler C.A. Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 15 (1995) 3526-3538
11. 5A receptor localization in the rat spinal cord suggests a role in nociception and control of pelvic floor musculature. J Comp Neurol 476 (2004) 316-329
12. 5A receptor gene and schizophrenia. J Psychiatr Res 38 (2004) 371-376
13. 5A receptors in discrete regions of the circadian timing system in the Syrian hamster. Brain Res 869 (2000) 178-185
14. 7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus. Brain Res 1008 (2004) 40-48
15. Duncan M.J., and Davis V.A. Cyclic AMP mediates circadian phase shifts induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus. Brain Res 1058 (2005) 10-16
16. 7 receptors in the suprachiasmatic nucleus. J Neurosci 21 (2001) 5351-5357
17. Erlander M.G., Lovenberg T.W., Baron B.M., de Lecea L., Danielson P.E., Racke M., et al. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc Nat Acad Sci 90 (1993) 3452-3456
18. 7 receptor antagonist with improved in vivo properties. Bioorg Med Chem Lett 12 (2002) 3341-3344
19. 5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur J Pharmacol 361 (1998) 299-309
20. 5A receptor-G protein coupling in E. coli and Sf9 cell membranes with membranes from Sf9 cells expressing mammalian G proteins. Recept Channels 7 (2001) 303-318
21. 7 receptors in the rodent suprachiasmatic nucleus. J Biol Rhythms 16 (2001) 19-24
22. 5A receptor mRNA in the rat brain. Neurosci Lett 379 (2005) 101-105
23. 7 receptor-like immunoreactivity in the rat cerebellum. J Chem Neuroanat 24 (2002) 65-74
24. 5A receptor. Neuron 22 (1999) 581-591
25. 5B receptor was lost during mammalian evolution. Eur J Pharmacol 418 (2001) 157-167
26. 7 receptor antagonist. Br J Pharmacol 130 (2000) 539-548
27. Harrison P.J. The neuropathology of schizophrenia-a critical review of the data and their interpretation. Brain 122 (1999) 593-624
28. 1 receptor subtypes to adenylyl cyclase. Mol Brain Res 61 (1998) 90-99
29. 5A receptor gene in alcoholics and healthy volunteers. Mol Brain Res 58 (1998) 217-220
30. 5A receptor polymorphism, Pro15Ser, to schizophrenia. Mol Psychiatry 6 (2001) 217-219
31. 7 receptor mRNAs in the rat brain. Mol Brain Res 88 (2001) 194-198
32. Lewis D.A., Pierri J.N., Volk D.W., Melchitzky D.S., and Woo T.U.W. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 46 (1999) 616-626
33. 7 antagonist: (R)-3-(2-(2-(4-methyl-piperidin-1-yl)ethyl)-pyrrolidine-1-sulfonyl)-phen ol (SB-269970). J Med Chem 43 (2000) 342-345
34. 7) Implicated in the regulation of mammalian circadian rhythms. Neuron 11 (1993) 449-458
35. 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. Mol Pharmacol 43 (1993) 313-319
36. 5 receptors. Curr Drug Targets-CNS Neurorol Disord. 3 (2004) 53-58
37. Nicholson R., Small J., Dixon A.K., Spanswick D., and Lee K. Serotonin receptor mRNA expression in rat dorsal root ganglion neurons. Neurosci Lett 337 (2003) 119-122
38. 5A receptors stably expressed in C6 gloma cells couple to multiple signal transduction pathways. J Neurochem 84 (2003) 222-232
39. 5A receptor-like immunoreactivity in the rat brain. Brain Res 867 (2000) 131-142
40. 5A serotonin receptor mRNA in the human brain. Mol Brain Res 56 (1998) 1-8
41. Pierce K., and Courchesne E. Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry 49 (2001) 655-664
42. Pierce P.A., Xie G.X., Levine J.D., and Peroutka S.J. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70 (1996) 553-559
43. 1D receptor family. EMBO J 11 (1992) 4779-4786
44. 5A) in the spinal cord. J Comp Neurol 476 (2004) 313-315
45. Rea M.A., and Pickard G.E. Serotonergic modulation of photic entrainment in the Syrian hamster. Biol Rhythm Res 31 (2000) 284-314
46. 7 receptors are involved in the control of micturition in urethane anaesthatized rats. Br J Pharmacol 140 (2003) 53-60
47. 5A serotonin receptor. FEBS Lett 355 (1994) 242-246
48. Roth B.L., Hanizavareh S.M., and Blum A.E. Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology 174 (2004) 17-24
49. Rusak B., and Zucker I. Neural regulation of circadian rhythms. Physiol Rev 59 (1979) 449-526
50. 1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease. Curr Pharm Des 8 (2002) 139-145
51. 5B receptor mRNA in the raphe nuclei: coexpression with serotonin transporter. Synapse 51 (2004) 102-111
52. 5A receptor gene: systematic screening for DNA sequence variation and linkage mapping on chromosome 7q34-q36 using a polymorphism in the 5′ untranslated region. Biochem Biophys Res Commun 233 (1997) 6-9
53. 5A receptors?. Synapse 54 (2004) 111-118
54. 7 receptors. Curr Drug Targets-CNS Neurorol Disord. 3 (2004) 81-90
55. 1A receptors. Br J Pharmacol 128 (1999) 158-164
56. 7 receptors. Br J Pharmacol 130 (2000) 409-417
57. 5A receptor-mediated inhibition of cyclic AMP accumulation in rat C6 glioma cells. J Neurosci Res 61 (2000) 75-81
58. 7 receptor antagonist, modulates REM sleep in rats. Br J Pharmacol 139 (2003) 705-714
59. 5A receptor. Eur J Pharmacol 494 (2004) 91-99
60. 5A receptors in the carotid body chemoreception pathway of rat. Neurosci Lett 278 (2000) 9-12
61. 5B receptor couples to a G protein in mammalian cell membranes. FEBS Lett 333 (1993) 25-31
62. 7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurones. Brain Res 755 (1997) 246-254